October brought along the much-anticipated “Cannabis 2.0” stage of legalization in Canada; while edible products won’t be sold until December, the market celebrated the policy.


Meanwhile, Zenabis Global (TSX:ZENA) suffered through a difficult month for its share price after investors proved to be skeptical of a new rights offering to raise additional capital.

Also during the month, Hadley Ford, CEO of iAnthus Capital Holdings (CSE:IAN,OTCQX:ITHUF), told the Investing News Network (INN) that the capital-raising landscape for marijuana companies has significantly changed, with stricter guidelines.

Zenabis makes case for rights offering as stock takes hit

As mentioned, Zenabis has had a difficult month, in part due to concerns surrounding a C$20.8 million rights offering revealed toward the end of October.

Prior to the rights offering, the company was already on the downturn following the announcement of a split and delay on the expansion of its site in Langley, British Columbia.

During a conference call with investors after the rights offering news, the executive team of the company defended the offering and described it as the best option at this time for Zenabis to raise capital without affecting valuations for its shareholders.

“Zenabis determined that it was not in the best interest of shareholders to raise incremental debt from non-traditional sources, given additional debt would’ve increased cash burn until it became cash flow positive (and) increased our overall leverage, and given the requirement to raise convertible debt would’ve been meaningfully dilutive to shareholders,” CEO Andrew Grieve told investors during the call.

The company admitted it could not complete a traditional unit raising and was hard against a convertible debt offering.

iAnthus exec paints gloomy picture for cannabis investing landscape

“The actual values that exist in the (cannabis) market today bear no resemblance to what the value of the actual companies are,” iAnthus’ Ford told INN in an interview.

The executive explained that a lot of companies are struggling to raise capital as they continue operations in thriving markets, such as the US.

“We’re all getting painted with the same brush,” Ford continued. “Six months ago, anyone who smoked a joint could raise US$100 million. Now? It’s tough.”

Watch the video above to get the full details on cannabis highlights for the month of October.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less